Monday, January 29, 2018 2:59:53 PM
As certain market sectors stall out, the biotechnology sector burst through its 2017 highs. This breakout will trigger a continued squeeze even higher on the iShares NASDAQ BioTech ETF $IBB. At a current price of $118.81, investors should expect further upside to a $133.00 target in the next month. Once there, investors should expect a sharp pull back and potential high for 2018. As a swing trader, I am patiently waiting to short that pivot high at $133.00 for a pull back to $114.50.
Gareth Soloway
InTheMoneyStocks
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM